Company
Technology
Team
Board of Directors
Management
Extended Management
Project Management
Partners & Advisors
Preclinical Research
Clinical Research
Strategic Investment
Investors
News
Company News
Scientific Publications
Contact
Scientific Publications
Promising Next-Generation SARS-CoV-2 Live Vaccine Demonstrates Remarkable Safety, Protection, and Immunity Profile in Pre-Clinical Studies
14 August 2024
READ MORE
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
25 February 2024
READ MORE
A non-transmissible live attenuated SARS-CoV-2 vaccine
26 May 2023
READ MORE
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
3 April 2023
READ MORE
Live-attenuated vaccines as a promising tool to defeat Covid-19
21 October 2022
READ MORE
Synthetically recoded virus sCPD9 - A tool to accelerate SARS-CoV-2 research under biosafety level 2 conditions
13 August 2022
READ MORE
Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
1 December 2021
READ MORE
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
19 July 2021
READ MORE